Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6460)
All Articles published online
|
Publishing Process of This Article
|
Oct 15, 2019 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li YS, Zou Y, Dai DQ. MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation. World J Gastrointest Oncol 2019; 11(10): 842-856 [PMID: 31662823 DOI: 10.4251/wjgo.v11.i10.842] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i10/842.htm |
| Number | Citing Articles |
| 1 |
Akanksha Khandelwal, Uttam Sharma, Tushar Singh Barwal, Rajeev Kumar Seam, Manish Gupta, Manjit Kaur Rana, Karen M. Vasquez, Aklank Jain. Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.645475
|
| 2 |
Xiang Ao, Wei Ding, Hu Ge, Yuan Zhang, Dan Ding, Ying Liu. PBX1 is a valuable prognostic biomarker for patients with breast cancer. Experimental and Therapeutic Medicine 2020; 20(1): 385 doi: 10.3892/etm.2020.8705
|
| 3 |
Huifeng Wang, Hui Dong, Lijiao Qiao, Yuanyuan Wu, Bo Wu, Xiangming Jin. ZEB1 induces non-small cell lung cancer development by targeting microRNA-320a to increase the expression of RAD51AP1. Experimental Cell Research 2021; 405(2): 112687 doi: 10.1016/j.yexcr.2021.112687
|
| 4 |
Jianjie Li, Xiaoyue Xu, Chunhui Liu, Xiaoxue Xi, Yang Wang, Xiaotang Wu, Hua Li. miR-181a-2-3p Stimulates Gastric Cancer Progression via Targeting MYLK. Frontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.687915
|
| 5 |
Tingsong Chen, Hao Wang, Hongzhu Yan. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients. Cell Cycle 2022; 21(19): 2079 doi: 10.1080/15384101.2022.2085359
|
| 6 |
Wei-Chun Chen, Ting-Chang Chang, Hung-Hsueh Chou, Mei-Hsiu Cheng, Jun-Jie Hong, Yi-Shan Hsieh, Chao-Min Cheng. Peritoneal Fluid Analysis of Advanced Ovarian Cancers after Hyperthermic Intraperitoneal Chemotherapy. International Journal of Molecular Sciences 2023; 24(11): 9748 doi: 10.3390/ijms24119748
|
| 7 |
Jie Jiang, Bin Liu, Ruilin Liu, Wenzhuo Yang. Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma. Cancer Management and Research 2021; : 2517 doi: 10.2147/CMAR.S296069
|
| 8 |
Yiqun Li, Jing Huang, Chaojun Hu, Jiaxin Zhou, Dong Xu, Yong Hou, Chanyuan Wu, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng, Changzheng Liu, Qian Wang, Yan Zhao. MicroRNA-320a: an important regulator in the fibrotic process in interstitial lung disease of systemic sclerosis. Arthritis Research & Therapy 2021; 23(1) doi: 10.1186/s13075-020-02411-9
|
| 9 |
Chaoqun Huang, Jiuyang Liu, Liang He, Fubing Wang, Bin Xiong, Yan Li, Xiaojun Yang. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development. Bioengineered 2021; 12(2): 11738 doi: 10.1080/21655979.2021.2009412
|
| 10 |
Ying Liu, Xiang Ao, Xuehao Zhou, Chengcheng Du, Shouxiang Kuang. The regulation of PBXs and their emerging role in cancer. Journal of Cellular and Molecular Medicine 2022; 26(5): 1363 doi: 10.1111/jcmm.17196
|
| 11 |
Yong-Shuang Li, Ying Zou, Dong-Qiu Dai. Correction to "MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation". World Journal of Gastrointestinal Oncology 2022; 14(6): 1216-1217 doi: 10.4251/wjgo.v14.i6.1216
|
| 12 |
Richard Morgan, Hardev S Pandha. PBX3 in Cancer. Cancers 2020; 12(2): 431 doi: 10.3390/cancers12020431
|
| 13 |
Yuanyuan Liang, Shun Li, Liling Tang. MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy. Biomedicines 2021; 9(6): 591 doi: 10.3390/biomedicines9060591
|
| 14 |
Chengyao Wan, Jing Wen, Xiaolin Liang, Qiongni Xie, Wenqi Wu, Meiqing Wu, Zhenfang Liu. Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80571-z
|
| 15 |
Min Lu, Chunhong Hu, Fang Wu, Long Shu, Yue Pan, Xianling Liu, Ping Liu, Fang Ma, Chao Deng, Ming Huang. MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data. Lung Cancer 2020; 147: 193 doi: 10.1016/j.lungcan.2020.06.020
|